TrialThe Journal of infectious diseases2022

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.

Ann R Falsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.